Log In
BCIQ
Print this Print this
 

Cervidil, Propess, dinoprostone

  Manage Alerts
Collapse Summary General Information
Company Ferring Pharmaceuticals A/S
DescriptionSustained release vaginal insert delivering a synthetic prostaglandin E2
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationUterine contractions
Indication DetailsPrepare cervix for labor
Regulatory Designation
PartnerAllergan plc;
CSL Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/31/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today